Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Sulfonamides"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 140
Tytuł:
Determination of Cyazofamid and Its Metabolite in Oily Agricultural Products with HPLC-MS/MS.
Autorzy:
Wang Y; Technology Center of Haikou Customs District, Haikou 570311, China.
Fu L; Technology Center of Haikou Customs District, Haikou 570311, China.
Xu Z; Technology Center of Haikou Customs District, Haikou 570311, China.
Ji S; Technology Center of Haikou Customs District, Haikou 570311, China.
Zhuang P; Technology Center of Haikou Customs District, Haikou 570311, China.
Pokaż więcej
Źródło:
Journal of chromatographic science [J Chromatogr Sci] 2022 Dec 13; Vol. 60 (10), pp. 970-976.
Typ publikacji:
Journal Article
MeSH Terms:
Tandem Mass Spectrometry*/methods
Sulfonamides*/analysis
Chromatography, High Pressure Liquid ; Imidazoles/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biosynthesis of sulfonamide and sulfamate antibiotics in actinomycete.
Autorzy:
Awakawa T; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.; Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan.
Barra L; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
Abe I; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.; Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan.
Pokaż więcej
Źródło:
Journal of industrial microbiology & biotechnology [J Ind Microbiol Biotechnol] 2021 Jun 04; Vol. 48 (3-4).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Actinobacteria/*metabolism
Anti-Bacterial Agents/*metabolism
Sulfonamides/*metabolism
Sulfonic Acids/*metabolism
Actinobacteria/chemistry ; Actinobacteria/genetics ; Anti-Bacterial Agents/chemistry ; Biological Products/chemistry ; Biological Products/metabolism ; Sulfonamides/chemistry ; Sulfonic Acids/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Rapid improvement of refractory generalized granuloma annulare with the Janus kinase inhibitor baricitinib in two patients.
Autorzy:
Kim D; Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
Kang HY; Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Mar 22; Vol. 48 (4), pp. 375-376.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Granuloma Annulare*/drug therapy
Janus Kinase Inhibitors*/therapeutic use
Azetidines*/therapeutic use
Humans ; Sulfonamides/therapeutic use
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tamsulosin for prevention of postoperative urinary retention: A systematic review and meta-analysis.
Autorzy:
Baysden M; Creighton University Center for Drug Information & Evidence-Based Practice, Omaha, NE, USA.
Hein D; Creighton University Center for Drug Information & Evidence-Based Practice, Omaha, NE, USA.
Castillo S; Creighton University Center for Drug Information & Evidence-Based Practice, Omaha, NE, USA.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2023 Mar 07; Vol. 80 (6), pp. 373-383.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Urinary Retention*/epidemiology
Urinary Retention*/etiology
Urinary Retention*/prevention & control
Urinary Tract Infections*/epidemiology
Urinary Tract Infections*/prevention & control
Male ; Humans ; Tamsulosin ; Quality of Life ; Sulfonamides/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases.
Autorzy:
Alfallouji Y; University College London Hospital NHS Trust, London, UK.
Spencer A; Imperial College NHS Trust, London, UK.
Calonje E; Guy's and St Thomas' NHS Foundation Trust, London, UK.
Perrett CM; University College London Hospital NHS Trust, London, UK.; The Devonshire Clinic, London, UK.
Watchorn R; Imperial College NHS Trust, London, UK.
Borysiewicz C; Imperial College NHS Trust, London, UK.
Hodgkinson T; Imperial College NHS Trust, London, UK.
Wasan H; Imperial College NHS Trust, London, UK.
Bunker CB; University College London Hospital NHS Trust, London, UK.
Sidwell RU; The Devonshire Clinic, London, UK.; West Hertfordshire Hospitals NHS Trust, London, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Oct; Vol. 47 (10), pp. 1857-1858. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Colonic Neoplasms*
Exanthema*
Nevus, Pigmented*/pathology
Rectal Neoplasms*
Skin Neoplasms*/chemically induced
Skin Neoplasms*/drug therapy
Skin Neoplasms*/pathology
Antineoplastic Combined Chemotherapy Protocols ; Carbamates ; Humans ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics ; Sulfonamides
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib.
Autorzy:
Joos L; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.
Vetterli F; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.
Jaeger T; PATHOdiagnostics, St Gallen, Switzerland.
Cozzio A; Department of Dermatology, Kantonsspital St Gallen, St Gallen, Switzerland.
von Kempis J; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.
Rubbert-Roth A; Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Apr; Vol. 47 (4), pp. 748-750. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:
Letter
MeSH Terms:
Lupus Erythematosus, Cutaneous*/drug therapy
Lupus Erythematosus, Cutaneous*/pathology
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/pathology
Azetidines ; Humans ; Purines ; Pyrazoles ; Skin/pathology ; Sulfonamides
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia.
Autorzy:
Kreuter A; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
Licciardi-Fernandez MJ; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
Burmann SN; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
Paschos A; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
Michalowitz AL; Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth, Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Apr; Vol. 47 (4), pp. 787-788. Date of Electronic Publication: 2022 Jan 18.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Lichen Planus*/complications
Lichen Planus*/drug therapy
Lupus Erythematosus, Cutaneous*/complications
Lupus Erythematosus, Cutaneous*/drug therapy
Alopecia/complications ; Alopecia/drug therapy ; Azetidines ; Humans ; Purines ; Pyrazoles ; Sulfonamides
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acute spondyloarthritis developing during successful treatment with dupilumab for severe atopic dermatitis.
Autorzy:
Raimondo A; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Guglielmi G; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Marino C; S. Giovanni di Dio e Ruggi D'Aragona University Hospital, PO Santa Maria Incoronata Dell'Olmo, Cava dè Tirreni, Salerno, Italy.
Ligrone L; S. Giovanni di Dio e Ruggi D'Aragona University Hospital, PO Santa Maria Incoronata Dell'Olmo, Cava dè Tirreni, Salerno, Italy.
Lembo S; Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 592-593. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Antibodies, Monoclonal, Humanized/*adverse effects
Dermatitis, Atopic/*drug therapy
Dermatologic Agents/*adverse effects
Osteoarthritis, Spine/*chemically induced
Adult ; Azetidines/therapeutic use ; Dermatologic Agents/therapeutic use ; Humans ; Janus Kinase 1/antagonists & inhibitors ; Janus Kinase 2/antagonists & inhibitors ; Male ; Osteoarthritis, Spine/diagnosis ; Osteoarthritis, Spine/drug therapy ; Purines/therapeutic use ; Pyrazoles/therapeutic use ; Sulfonamides/therapeutic use
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quantification and In Silico Toxicity Assessment of Nimesulide and its Related Substances.
Autorzy:
Nagulakonda NNM; Department of analytical chemistry, Dermatology, proprietary products, IPDO innovation plaza, Bachupally, Hyderabad, Telangana 500090, India.; Department of Inorganic & Analytical Chemistry, Andhra University, Visakhapatnam 530003, India.
Ananthula RS; Department of analytical chemistry, Dermatology, proprietary products, IPDO innovation plaza, Bachupally, Hyderabad, Telangana 500090, India.
Susarla KPC; Department of analytical chemistry, Dermatology, proprietary products, IPDO innovation plaza, Bachupally, Hyderabad, Telangana 500090, India.
Krishnamurthy T; Department of analytical chemistry, Dermatology, proprietary products, IPDO innovation plaza, Bachupally, Hyderabad, Telangana 500090, India.
Gollapalli NR; Department of Inorganic & Analytical Chemistry, Andhra University, Visakhapatnam 530003, India.
Pokaż więcej
Źródło:
Journal of chromatographic science [J Chromatogr Sci] 2017 May 01; Vol. 55 (5), pp. 508-517.
Typ publikacji:
Journal Article
MeSH Terms:
Computer Simulation*
Sulfonamides*/analysis
Sulfonamides*/chemistry
Sulfonamides*/toxicity
Chromatography, High Pressure Liquid/*methods
Animals ; Drug Contamination ; Humans ; Limit of Detection ; Linear Models ; Mass Spectrometry/methods ; Quantitative Structure-Activity Relationship ; Rats ; Reproducibility of Results ; Skin Irritancy Tests ; Software
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Use of an argatroban systemic infusion and purge solution in a patient with a percutaneous ventricular assist device with suspected heparin-induced thrombocytopenia.
Autorzy:
Shtoyko AN; Department of Pharmacy, Upstate University Hospital, Syracuse, NY, USA.
Feldman EA; Department of Pharmacy, Upstate University Hospital, Syracuse, NY.; Upstate Pharmacy Services Translational Research Team (UPSTART), Syracuse, NY, USA.
Cwikla GM; Department of Pharmacy, Upstate University Hospital, Syracuse, NY.; Upstate Pharmacy Services Translational Research Team (UPSTART), Syracuse, NY, USA.
Darko W; Department of Pharmacy, Upstate University Hospital, Syracuse, NY.; Department of Medicine, Upstate Medical University, Syracuse, NY, USA.
Green GR; Department of Surgery, Upstate Medical University, Syracuse, NY, USA.
Seabury RW; Department of Pharmacy, Upstate University Hospital, Syracuse, NY.; Department of Medicine, Upstate Medical University, Syracuse, NY, USA.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Jan 01; Vol. 79 (1), pp. e8-e13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Heart-Assist Devices*
Thrombocytopenia*/chemically induced
Thrombocytopenia*/diagnosis
Thrombocytopenia*/drug therapy
Adult ; Arginine/analogs & derivatives ; Humans ; Pipecolic Acids ; Sulfonamides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.
Autorzy:
Cartron AM; Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA.
Nguyen TH; Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA.
Roh YS; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kwatra MM; Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.
Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jul; Vol. 46 (5), pp. 820-824. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Dermatitis, Atopic/*drug therapy
Dermatitis, Atopic/*immunology
Janus Kinase Inhibitors/*pharmacology
Janus Kinase Inhibitors/*therapeutic use
Acetonitriles/administration & dosage ; Acetonitriles/pharmacology ; Acetonitriles/therapeutic use ; Administration, Oral ; Administration, Topical ; Adult ; Azetidines/administration & dosage ; Azetidines/pharmacology ; Azetidines/therapeutic use ; Child ; Dermatitis, Atopic/physiopathology ; Dermatitis, Atopic/psychology ; Heterocyclic Compounds, 3-Ring/administration & dosage ; Heterocyclic Compounds, 3-Ring/pharmacology ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Humans ; Janus Kinase 1/antagonists & inhibitors ; Janus Kinase 2/antagonists & inhibitors ; Janus Kinase 3/antagonists & inhibitors ; Janus Kinase Inhibitors/administration & dosage ; Nitriles/administration & dosage ; Nitriles/pharmacology ; Nitriles/therapeutic use ; Piperidines/administration & dosage ; Piperidines/pharmacology ; Piperidines/therapeutic use ; Purines/administration & dosage ; Purines/pharmacology ; Purines/therapeutic use ; Pyrazoles/administration & dosage ; Pyrazoles/pharmacology ; Pyrazoles/therapeutic use ; Pyridazines/administration & dosage ; Pyridazines/pharmacology ; Pyridazines/therapeutic use ; Pyrimidines/administration & dosage ; Pyrimidines/pharmacology ; Pyrimidines/therapeutic use ; Quality of Life ; STAT1 Transcription Factor/pharmacology ; Safety ; Severity of Illness Index ; Sulfonamides/administration & dosage ; Sulfonamides/pharmacology ; Sulfonamides/therapeutic use ; TYK2 Kinase/antagonists & inhibitors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome.
Autorzy:
Nousari Y; Integral Rheumatology & Immunology Specialists, Plantation, FL, USA.
Wu BC; Broward Health Medical Center Dermatology Residency Program, Fort Lauderdale, FL, USA.
Valenzuela G; Integral Rheumatology & Immunology Specialists, Plantation, FL, USA.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Oct; Vol. 46 (7), pp. 1330-1332. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Arthritis, Rheumatoid/*complications
Azetidines/*therapeutic use
Janus Kinase Inhibitors/*therapeutic use
Purines/*therapeutic use
Pyrazoles/*therapeutic use
Sulfonamides/*therapeutic use
Sweet Syndrome/*drug therapy
Antirheumatic Agents/therapeutic use ; Arthritis, Rheumatoid/drug therapy ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Middle Aged ; Skin/pathology ; Sweet Syndrome/etiology ; Sweet Syndrome/pathology
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Simultaneous Determination of Bosentan, Glimepiride, HYBOS and M1 in Rat Plasma by UPLC-MS-MS and its Application to Pharmacokinetic Study.
Autorzy:
Chen M; The 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China School of Pharmacy of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Song W; The 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Wang S; The Laboratory of Clinical Pharmacy, People's Hospital of Lishui City, Lishui, Zhejiang 323000, China.
Chen Q; School of Pharmacy of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Pan P; School of Pharmacy of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Xu T; School of Pharmacy of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Hu G; School of Pharmacy of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Zheng Z; The 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China zhe_.
Pokaż więcej
Źródło:
Journal of chromatographic science [J Chromatogr Sci] 2016 Aug; Vol. 54 (7), pp. 1159-65. Date of Electronic Publication: 2016 May 30.
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
Chromatography, High Pressure Liquid/*standards
Sulfonamides/*blood
Sulfonylurea Compounds/*blood
Tandem Mass Spectrometry/*standards
Administration, Oral ; Animals ; Bosentan ; Chromatography, High Pressure Liquid/methods ; Hydroxylation ; Male ; Observer Variation ; Phenylpropionates/blood ; Protein Denaturation ; Pyridazines/blood ; Rats ; Rats, Sprague-Dawley ; Reference Standards ; Reproducibility of Results ; Sensitivity and Specificity ; Sulfonamides/pharmacokinetics ; Sulfonylurea Compounds/pharmacokinetics ; Tandem Mass Spectrometry/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.
Autorzy:
Sagardia LM; Emory Saint Joseph's Hospital, Atlanta, GA.
Daniels LM; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Emory Saint Joseph's Hospital, Atlanta, GA.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2020 Nov 16; Vol. 77 (23), pp. 1961-1964.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Anticoagulants/*therapeutic use
Coronavirus Infections/*complications
Fibrinolytic Agents/*therapeutic use
Pipecolic Acids/*therapeutic use
Pneumonia, Viral/*complications
Pulmonary Embolism/*drug therapy
Pulmonary Embolism/*etiology
Thrombolytic Therapy/*methods
Adult ; Arginine/analogs & derivatives ; COVID-19 ; Heart Arrest/etiology ; Heart Arrest/therapy ; Heparin, Low-Molecular-Weight/therapeutic use ; Humans ; Male ; Pandemics ; Sulfonamides ; Treatment Failure ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
TRIO Method for Detection of Beta-Lactams, Sulfonamides, and Tetracyclines in Raw Commingled Cows' Milk.
Autorzy:
Salter RS; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Markovsky RJ; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Douglas DW; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Saul SJ; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Tran AC; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Legg DR; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Schwartz JA; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Conaway DM; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
McRobbie LW; Charm Sciences, Inc., 659 Andover St, Lawrence, MA 01843, USA.
Kalinowski E; Eurofins-DQCI, 5205 Quincy Street, Mounds View, MN 55112, USA.
Bulthaus M; Eurofins-DQCI, 5205 Quincy Street, Mounds View, MN 55112, USA.
Pokaż więcej
Źródło:
Journal of AOAC International [J AOAC Int] 2020 Sep 01; Vol. 103 (5), pp. 1366-1377.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Residues*/analysis
beta-Lactams*/analysis
Animals ; Anti-Bacterial Agents/analysis ; Canada ; Cattle ; Female ; Food Contamination/analysis ; Milk/chemistry ; Sulfonamides ; Tetracyclines/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A Green HPLC Method for Determination of Nine Sulfonamides in Milk and Beef, and Its Greenness Assessment with Analytical Eco-Scale and Greenness Profile.
Autorzy:
Duan X; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.; Lanzhou University of Technology, School of Life Science and Engineering, Lanzhou, PR China.
Liu X; Lanzhou University of Technology, School of Life Science and Engineering, Lanzhou, PR China.
Dong Y; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.
Yang J; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.
Zhang J; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.
He S; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.
Yang F; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.
Wang Z; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.
Dong Y; Lanzhou University, Institute of Pharmaceutical Analysis, School of Pharmacy, Lanzhou, PR China.; Lanzhou University-Techcomp (China) Ltd. Joint Laboratory of Pharmaceutical Analysis, Lanzhou, PR China.
Pokaż więcej
Źródło:
Journal of AOAC International [J AOAC Int] 2020 Jul 01; Vol. 103 (4), pp. 1181-1189.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Residues*
Milk*/chemistry
Animals ; Cattle ; Chromatography, High Pressure Liquid ; Reproducibility of Results ; Sulfonamides/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn´s Disease.
Autorzy:
Rojo E; Gastrointestinal Unit from Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP], and Universidad Autónoma de Madrid, Madrid, Spain.
Chaparro M; Gastrointestinal Unit from Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP], and Universidad Autónoma de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBERehd], Madrid, Spain.
García-Buey L; Gastrointestinal Unit from Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa [IIS-IP], and Universidad Autónoma de Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2020 May 21; Vol. 14 (4), pp. 567-568.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Aminoisobutyric Acids/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Benzimidazoles/*therapeutic use
Crohn Disease/*drug therapy
Cyclopropanes/*therapeutic use
Hepatitis C/*complications
Lactams, Macrocyclic/*therapeutic use
Leucine/*analogs & derivatives
Porphyria Cutanea Tarda/*virology
Proline/*analogs & derivatives
Quinoxalines/*therapeutic use
Sulfonamides/*therapeutic use
Crohn Disease/complications ; Gastrointestinal Agents/therapeutic use ; Hepatitis C/drug therapy ; Humans ; Leucine/therapeutic use ; Male ; Middle Aged ; Porphyria Cutanea Tarda/drug therapy ; Proline/therapeutic use ; Pyrrolidines
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 140

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies